期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
桂枝的薄层鉴别及含量测定 被引量:4
1
作者 欧阳罗丹 肖苏萍 +5 位作者 周建新 陈蒙 邓哲 周海燕 杜杰 王继永 《中国药物警戒》 2022年第4期380-383,共4页
目的对《中华人民共和国药典》(2020年版)中桂枝的薄层鉴别和含量测定方法进行改进。方法以桂皮醛、肉桂酸、桂枝对照药材为对照品,对桂枝药材进行了薄层鉴别和含量测定条件的研究;并对不同产地的桂枝药材进行薄层鉴别和含量测定。结果... 目的对《中华人民共和国药典》(2020年版)中桂枝的薄层鉴别和含量测定方法进行改进。方法以桂皮醛、肉桂酸、桂枝对照药材为对照品,对桂枝药材进行了薄层鉴别和含量测定条件的研究;并对不同产地的桂枝药材进行薄层鉴别和含量测定。结果薄层色谱斑点清晰,分离度好,易于检出,重现性佳。含量测定方法分离效率高,重复性好。结论所建立的桂枝薄层鉴别和含量测定方法简单、专属性强,可同时检测桂枝中的桂皮醛、肉桂酸,可为药典的修订提供参考。 展开更多
关键词 桂枝 薄层鉴别 含量测定 桂皮醛 肉桂酸
下载PDF
苓桂术甘汤的现代临床应用与分析 被引量:4
2
作者 王璐瑶 邓哲 +6 位作者 肖苏萍 张权 欧阳罗丹 陈蒙 周海燕 王继永 杜杰 《中国药物警戒》 2021年第11期1066-1069,1074,共5页
目的了解苓桂术甘汤现代临床应用概况和优势病种,为经典名方苓桂术甘汤复方制剂开发和临床应用提供参考,也为其他经典名方现代临床应用分析分享思路。方法检索1979年1月1日至2020年2月11日中国知网、维普网、万方数据等数据库相关文献,... 目的了解苓桂术甘汤现代临床应用概况和优势病种,为经典名方苓桂术甘汤复方制剂开发和临床应用提供参考,也为其他经典名方现代临床应用分析分享思路。方法检索1979年1月1日至2020年2月11日中国知网、维普网、万方数据等数据库相关文献,并用Excel 2010对主治病症、病例数、药味组成、组方特点、药味剂量、用法用量、有效率和不良反应等关键信息整理、统计,从数据角度阐明苓桂术甘汤临床概况和优势病种,并对优势病种分析。结果符合要求的现代临床文献共计543篇,发现苓桂术甘汤在现代临床应用方面呈现主治病症较多、病例数多集中50~99例、药味组成以加味为主、总有效率超90%、药品不良反应少等特点;心力衰竭为苓桂术甘汤现代临床优势病种之一,心力衰竭治疗方表现药味组成仍然基于原方,药味剂量多样,以茯苓(30、15、20 g),桂枝(10、15、6 g),白术(15、10、20 g),甘草(6、10、3 g)常见;服用方法为水煎煮,每日1剂,分2~3次服,每次100~200 mL;组方规律以加减益气、活血、利水药味进行配伍。结论本文通过对苓桂术甘汤现代临床应用概况和优势病种进行分析,可以为其研制提供临床资料,指导其产业化的临床应用。 展开更多
关键词 经典名方 苓桂术甘汤 现代临床 优势病种 心力衰竭
下载PDF
Protective effect of Yiguanjian decoction against DNA damage on concanavalin A-induced liver injury mice model 被引量:7
3
作者 Tian Mengxi Liu Wenlan +5 位作者 You Hongjie Zhao Qingzhou ouyang luodan Gao Biane Zhang Xin Che Niancong 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2016年第4期471-478,共8页
OBJECTIVE:To investigate the inhibitory effect of Yiguanjian decoction(YD) on DNA damage in Concanavalin A(Con A)-induced liver injury mice model and to explain the possible mechanism.METHODS:Totally 120 male BALB/c m... OBJECTIVE:To investigate the inhibitory effect of Yiguanjian decoction(YD) on DNA damage in Concanavalin A(Con A)-induced liver injury mice model and to explain the possible mechanism.METHODS:Totally 120 male BALB/c mice were randomly divided into 6 groups,20 mice each:normal group,model group,Bifendate group,YD low dose group,YD middle dose group and YD high dose group.Except normal group,liver injury model induced by Con A was established.While modeling,each mouse in YD group was given YD(0.4 m L/20 g per day) by intragastric administration(0.13 g YD for YD low dose group;0.26 g for YD middle dose group;0.52 g for YD high dose group).Bifendate group was given Bifendate(0.2 gnd model·kg-1 grou·d-1) by gavage.Normal group ap were fed with same volume of physiological saline daily.After 8 weeks,the serum alanine transaminase(ALT)and aspartate transaminase(AST) were tested.The hematoxylin-eosin staining was used to evaluate the grade of liver inflammation and liver fibrosis stage.Hepatocellular DNA damage was detected by single cell gel electrophoresis technology.The protein expression of tumor necrosis factor-α(TNF-α),Bax and Mut T Homolog 1(MTH1) was detected by western blotting and enzyme linked immunosorbent assay.Bax m RNA and MTH1 m RNA were detected by Real-time Polymerase Chain Reaction(PCR).RESULTS:YD can improve the degree of liver inflammation and fibrosis in the liver of chronic hepatitis mice,the dose effect relationship is remarkable(P < 0.05).YD can reduce liver cell DNA damage.The difference between YD middle dose group and model group was statistically significant(P < 0.05).YD middle dose group had decreased the protein expression of TNF-α in the mice liver of immunological liver injury(P < 0.05).YD can increase the protein expression of Bax(P < 0.05).Compared with normal group,the protein expression of MTH1 was decreased(P < 0.05),but there was no statistical significance between YD group and model group(P >0.05).YD can increase the m RNA expression of Bax and MTH1(both P < 0.05).CONCLUSION:YD can effectively inhibit the DNA damage in immunological liver injury mice,the mechanism may be that it can decrease the TNF-αand increase the Bax and MTH1 expression. 展开更多
关键词 Drug-induced liver injury Liver kidney Yin deficiency DNA damage Concanavalin A Yiguanjian decoction
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部